CytoMed Therapeutics Limited NASDAQ:GDTC

CytoMed Therapeutics Limited stock price today

$1.75
-1.14
-39.45%
Financial Health
0
1
2
3
4
5
6
7
8
9

CytoMed Therapeutics Limited stock price monthly change

+42.37%
month

CytoMed Therapeutics Limited stock price quarterly change

+42.37%
quarter

CytoMed Therapeutics Limited stock price yearly change

-44.42%
year

CytoMed Therapeutics Limited key metrics

Market Cap
29.54M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.41
Revenue
N/A
EBITDA
-4.10M
Income
-5.34M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CytoMed Therapeutics Limited stock price history

CytoMed Therapeutics Limited stock forecast

CytoMed Therapeutics Limited financial statements

CytoMed Therapeutics Limited (NASDAQ:GDTC): Profit margin
Jun 2022 0 -729.06K
Dec 2022 0 -1.53M
Jun 2023 0 -1.61M
Dec 2023 0 -1.46M
CytoMed Therapeutics Limited (NASDAQ:GDTC): Analyst Estimates
2025 690.90K -3.53M -511.08%
  • Analysts Price target

  • Financials & Ratios estimates

CytoMed Therapeutics Limited (NASDAQ:GDTC): Debt to assets
Mar 2023 13914925 746.07K 5.36%
Jun 2023 13914925 746.07K 5.36%
Sep 2023 12368870 1.12M 9.09%
Dec 2023 12368870 1.12M 9.09%
CytoMed Therapeutics Limited (NASDAQ:GDTC): Cash Flow
Jun 2022 -400.57K -309.17K -28.1K
Dec 2022 -693.47K -30.69K 813.59K
Jun 2023 -1.55M -12.81K 8.20M
Dec 2023 -1.02M -2.08M -78.42K

CytoMed Therapeutics Limited alternative data

CytoMed Therapeutics Limited (NASDAQ:GDTC): Employee count
Mar 2024 28
Apr 2024 28
May 2024 28
Jun 2024 28
Jul 2024 28

CytoMed Therapeutics Limited other data

Wednesday, 17 July 2024
globenewswire.com
Wednesday, 20 March 2024
accesswire.com
Monday, 18 March 2024
globenewswire.com
Monday, 4 March 2024
globenewswire.com
Monday, 29 January 2024
globenewswire.com
Tuesday, 5 December 2023
prnewswire.com
Friday, 17 November 2023
prnewswire.com
Tuesday, 14 November 2023
PRNewsWire
Friday, 1 September 2023
Seeking Alpha
Thursday, 17 August 2023
Newsfile Corp
  • What's the price of CytoMed Therapeutics Limited stock today?

    One share of CytoMed Therapeutics Limited stock can currently be purchased for approximately $1.75.

  • When is CytoMed Therapeutics Limited's next earnings date?

    Unfortunately, CytoMed Therapeutics Limited's (GDTC) next earnings date is currently unknown.

  • Does CytoMed Therapeutics Limited pay dividends?

    No, CytoMed Therapeutics Limited does not pay dividends.

  • How much money does CytoMed Therapeutics Limited make?

    CytoMed Therapeutics Limited has a market capitalization of 29.54M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 20.16% to 290.56K US dollars.

  • What is CytoMed Therapeutics Limited's stock symbol?

    CytoMed Therapeutics Limited is traded on the NASDAQ under the ticker symbol "GDTC".

  • What is CytoMed Therapeutics Limited's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CytoMed Therapeutics Limited?

    Shares of CytoMed Therapeutics Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does CytoMed Therapeutics Limited have?

    As Jul 2024, CytoMed Therapeutics Limited employs 28 workers.

  • When CytoMed Therapeutics Limited went public?

    CytoMed Therapeutics Limited is publicly traded company for more then 2 years since IPO on 14 Apr 2023.

  • What is CytoMed Therapeutics Limited's official website?

    The official website for CytoMed Therapeutics Limited is w2.cytomed.sg.

  • How can i contact CytoMed Therapeutics Limited?

    CytoMed Therapeutics Limited can be reached via phone at +65 6250 7738.

CytoMed Therapeutics Limited company profile:

CytoMed Therapeutics Limited

w2.cytomed.sg
Exchange:

NASDAQ

Full time employees:

28

Industry:

Biotechnology

Sector:

Healthcare

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.

1 Commonwealth Lane, No. 08-22
Singapore, 149544

CIK: 0001873093
ISIN: SGXZ17669631
: